COVID-19, with its complications and co-infections is the most important pandemic, which has placed great strain on even the most developed health care systems, especially on the kidney transplant patients. We present a case of cytomegalovirus (CMV) reactivation after remission of COVID-19 in a kidney transplant patient, admitted to the emergency department. Fever, dyspnea, weakness and tachypnea are the most common symptoms of COVID-19, which can mislead physicians to make inappropriate decisions. We concluded that CMV can potentially increase the mortality risk of kidney transplant recipients (KTRs).
Implication for health policy/practice/research/medical education:
This case study can help physicians for consideration of the possibility of cytomegalovirus (CMV) in critically ill patients whose clinical condition is deteriorating.
Please cite this paper as: Alizadeh M, Elsagh A, Mohamadi Afrakoti M, Khavari Z. Cytomegalovirus infection after COVID-19 in a kidney transplant patient, a case report. J Renal Inj Prev. 2023; 12(1): e32042. doi: 10.34172/jrip.2023.32042.